UNSPSC 51371907: Methadone

This classification denotes an opiate with the molecular formula C21H27NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UC6VBE7V1Z, chemically known as 6-dimethylamino-4,4-diphenyl-heptan-3-one but generally known as methadone, which bears US NIH Compound Identifier 4095. European Medicines Agency schedules Methadone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08833MIG. The term METHADONE is an International Non-Proprietary Name.

UNSPSC 51371907 Methadone is a Commodity code covering pharmaceutical products procured by state and local health agencies, though recent activity shows this code captures a broader pharmaceutical and harm-reduction procurement landscape that extends well beyond methadone alone. State and local buyers under this code are acquiring naloxone, generic multi-source pharmaceuticals, over-the-counter products, and direct-to-manufacturer prescription programs through both standalone purchases and cooperative purchasing arrangements. The issuing bodies are state health and human services departments, county health systems, and multistate cooperative purchasing alliances coordinating procurements across participating jurisdictions. Work solicited includes competitive bidding for specific drug products with defined NDCs and packaging configurations, participation in multi-vendor pharmacy networks through authorized wholesalers, and exploratory market-intelligence gathering for novel direct-contracting models.

Recent opportunities span Florida, Minnesota (coordinating with Oregon and other MMCAP members), and Texas. Seminole County, Florida released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023 and quarterly deliveries to the Seminole County Community Health Building in Sanford. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 on January 20, 2026, requesting generic multi-source pharmaceuticals and OTC products through three authorized wholesalers with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities regarding direct-to-manufacturer prescription programs for state pharmacy benefit management outside traditional PBM and wholesaler channels. Contracts typically require cGMP and DSCSA compliance, substantial insurance coverage including commercial general liability of $2 million to $5 million per occurrence, and submission through state e-procurement portals.